Replication-deficient adenovirus (Ad vector) is one of the most effective gene transfer systems. However, its employment in human gene therapy trials is hampered by Ad vector associated cytotoxicity and induction of apoptosis of the infected cells. Here, we identify one underlying mechanism as uncoupling of S phase and mitosis of the cell cycle leading to apoptosis and decline of transgene expression. Moreover, we demonstrate a strategy to avoid Ad vector associated cytotoxicity and induction of apoptosis in human primary hepatocytes by coinfection of Ad vector carrying the cDNA of choice and the cell cycle regulator p21 WAF1/CIP1 (p21). In addition, animal experiments were performed using Ad vector directed coexpression of p21 and human a 1-antitrypsin. As serum analysis of a 1-antitrypsin after Ad vector mediated gene transfer to the liver of mice revealed, this strategy resulted also in the improvement of transgene expression by two orders of magnitude. These data suggest that coexpression of p21 and Ad vector carrying a therapeutic gene may be a promising strategy to avoid cytotoxicity and induction of apoptosis leading to improved safety in human gene therapy.
Introduction
The liver plays a critical role in maintaining homeostasis of the human organism because of its essential metabolic functions. Based on its manifold actions, it is recognized to be the host of many inherited and acquired disorders. In addition, it is involved in eliminating infectious agents and, by itself, is often the target of severe, sometimes irreversible infections such as various forms of viral hepatitis. Moreover, liver function is often impaired by malignancies like primary hepatocellular carcinoma or metastasis of distant tumors like colorectal cancer. Therefore, this organ is in the focus of a variety of new therapeutic strategies like liver transplantation, tissue engineering or gene therapy. 1, 2 As nuclear DNA viruses like adenovirus infect nondividing, i.e. resting cells very efficiently, replicationdeficient recombinant adenoviruses (Ad vector) are commonly used to transfer genes into hepatocytes in vitro and in vivo. 3, 4 Besides the immune responses against the Ad vector and infected cells, this capability is limited by the Ad vector associated cytotoxicity and induction of apoptosis. [5] [6] [7] These effects are, at least in part, due to the interference of the Ad vector with the host cell metabolism and cell cycle regulation. As demonstrated, activating the host cell by adenoviral genes in favor of foreign gene expression is of advantage for transgene expression in terminally differentiated cells. 8, 9 On the contrary, the Ad vector stimulates the host cell cycle machinery at the expense of normal cell cycle regulation leading to an arrest in G 2 /M of the cell cycle. 10 In addition, Ad vector induces apoptosis which can be blocked by the oncogene bcl-2. 11, 12 Since Ad vector interferes with the host cell cycle machinery it should be useful to develop strategies that modulate Ad vector infection in favor of transgene expression while preventing Ad vector associated cytotoxicity and apoptosis. One promising candidate gene is p21 WAF1/CIP1 (p21) which controls the G 1 -and, most important, the G 2 -phase of cell cycle regulation in eukaryotic cells 13, 14 . It belongs to the p21 family of inhibitors of cyclin-dependent kinase which includes p21, p27 KIP1 and p57
KIP2
. After transcriptional activation during G 1 -phase, p21 induces G 1 -arrest through inactivation of cyclin-dependent kinase 2 (cdk2), which therefore cannot phosphorylate the retinoblastoma gene product (Rb). The resulting hypophosphorylated Rb prevents cell cycle transition from G 1 -to S-phase. While p21 does not play a role in S-phase during normal cell cycle progression, it has a major checkpoint activity in the G 2 -phase of the cell cycle (G 2 ) by controlling cell cycle progression from S-phase to mitosis. Here, expression of p21 leads to G 2 -arrest of the damaged cells. 15 Consequently, chemically or physically induced stress leads to uncoupling of S-phase and mitosis (S/M uncoupling) in cells with insufficient p21 expression. 16 The checkpoint activity during G 2 distinguishes p21 as a favorable candidate to prevent Ad vector associated cytotoxicity and induction of apoptosis. Therefore, we investigated the effect of coexpression of p21 on Ad vector mediated gene transfer to cell lines, the liver of experimental animals and human primary hepatocytes. The data suggest that coexpression of p21 and Ad vector carrying a therapeutic gene may be a promising strategy to avoid cytotoxicity and apoptosis leading to improved safety in human gene therapy.
Results

Ad vector induces apoptosis of infected cells by uncoupling of S-phase and mitosis
Upon cellular stress by cytotoxic chemicals or irradiation, p21-defective cells fail to stop cycling to allow repair resulting in an aberrant cell cycle and induction of apoptosis. Functionally, this process is characterized by an initial G 2 -like arrest followed by uncoupling of Sphase and mitosis (S/M-uncoupling). Morphologically, it is characterized by the presence of grossly deformed and multiple nuclei. 16 Because cell cycle dysregulation in G 2 can also be induced by first generation Ad vectors (Ad vector), we were interested to know if this side effect is also characterized by S/M-uncoupling, deformed nuclear morphology and apoptosis. To this end, we infected LoVo cells with an Ad vector coding for human a lantitrypsin (hAAT) as reporter gene (AdRSV-hAAT.2) and analyzed cell cycle distribution and induction of apoptosis. After mock infection, FACS-analysis of the viable, i.e. Annexin V-negative, population demonstrated the majority of cells in G 0 /G 1 ( Figure 1a ). In contrast, the viable population of Ad vector infected cells showed the majority of cells having a DNA content in G 2 /M or above G 2 /M (Figure 1b ). This effect was even more apparent when the total, i.e. viable and apoptotic, cell population was analyzed demonstrating the occurrence of aneuploid cells with 44N DNA content only in Ad vector infected cells (Figure 1c and arrow to the right of the peak at G 2 / M in Figure 1d ). In addition, Ad vector infected cells clearly showed a fraction of cells with a sub-G 0 /G 1 DNA content suggesting the presence of apoptosis (Figure 1c  and d) . Consequently, the in situ detection of DNA fragmentation indicating apoptotic cells (TUNEL) resulted in positive staining of Ad vector infected cells whereas mock controls demonstrated nearly no staining (Figure 1e and f). More strikingly, microscopic examination revealed an increase in the overall cell size and the presence of grossly deformed and multiple nuclei only in Ad vector infected cells (Figure 1e and f).
Ad vector associated apoptosis can be prevented by gene transfer of p21
The mechanism of induction of apoptosis by S/Muncoupling was identified in p21 defective cells. However, Ad vector infected LoVo cells were positive for p21 suggesting that mechanisms other than p21 deletion may play a role in Ad vector induced apoptosis. One possibility is that the level of p21 expression is not sufficient because its function can be neutralized by stoichiometric binding of p21 by cyclin B/CDC2 complexes which are upregulated during Ad vector infection. 10 Therefore, we hypothesized that overexpression of p21 may prevent Ad vector induced apoptosis. To test this hypothesis, we infected LoVo cells with an Ad vector coding for p21 (AdCMV.p21) and analyzed infected cells by TUNEL assay. In contrast to AdRSV-hAAT.2 infection, no apoptosis was seen in AdCMV.p21 infected cells (Figure 2b and c) . In addition, microscopic inspection of the morphology of AdCMV.p21 infected LoVo cells demonstrated the complete absence of enlarged cells and lack of aberrant nuclear morphology as compared to AdRSV-hAAT.2 infected cells (cf. Figure 2e and f). These results were corroborated by the lack of cells with a DNA content 44N in the FACS analysis of AdCMV.p21 infected LoVo cells (data not shown).
p21 can prevent Ad vector induced apoptosis even in the presence of adenoviral replication Based on the observation that gene transfer of p21 can prevent Ad vector associated apoptosis, we were interested to see if this ability of p21 is independent of the status of adenoviral replication. To answer this question, we amplified AdCMV.p21 on 293 cells. This cell line Prevention of Ad vector induced apoptosis by coexpression of p21 is mediated by recoupling Sphase and mitosis leading to reconstitution of normal cell cycle progression during G 2 p21 regulates cell cycle progression in G 1 and G 2 . Thus, we were interested to determine whether the protective function of p21 was mediated due to G 1 -arrest by Dcdk protein is not subject to phosphorylation and, therefore, prevents G 1 /S transition. 17 Thus, LoVo cells were mock treated or infected with AdCMV.Rb Dcdk , AdRSV-hAAT.2 or AdCMV.p21 and analyzed by FACS for cell cycle distribution and the presence of apoptosis. Comparing the extent of apoptosis by microscopic examination, AdCMV.Rb Dcdk and AdRSV-hAAT.2 infected cells showed a substantial increase in the fraction of apoptotic cells as compared to mock treated controls (increase in apoptosis in Table 1 ). In addition, the number of viable cells 96 h after infection was in the same range for AdCMV.Rb
Dcdk and AdRSVhAAT.2 infected cultures, indicating that hypophosphorylated Rb did not influence Ad vector associated apoptosis (cell number in Table 1 ). In contrast to AdCMV.Rb
Dcdk and AdRSV-hAAT.2 infected cultures, the extent of apoptosis in AdCMV.p21 infected cultures was as low as in the mock infected control and cell counts after 96 h showed no difference (Increase in apoptosis and cell number in Table 1 ). This ruled out the possibility that p21 protected the cells from apoptosis simply by arresting cells in G 1 Coinfection of AdCMV.p21 with a second Ad vector protects from Ad vector associated cytotoxicity and enhances expression of the second transgene
The ability of p21 to protect from Ad vector associated cytotoxicity and induction of apoptosis suggests that coexpression of p21 may support the expression of a transgene delivered by a second Ad vector. To test this hypothesis, we performed different coexpression experiments using 1:1 mixtures of different Ad vector. First, we infected LoVo cells with AdCMV.p21 and AdCMV.b-gal, an Ad vector carrying b-galactosidase. As controls, mock infected cells were used or cells infected with equal amounts of AdCMV.b-gal and AdCMV.Null which carries an empty expression cassette. After infection, culture supernatant was analyzed for glucose concentration and level of lactate dehydrogenase (LDH) as a measure of energy metabolism and cytotoxicity, respectively. Consistent with the fact that we infected with equal amounts of Ad vector mixtures, comparable amounts of glucose were metabolized as demonstrated by the decrease in glucose concentration in the culture medium in both infected LoVo cultures as compared to mock treated cells (Figure 4a ). In contrast, the two Ad vector infected groups showed opposite effects with regard to cytotoxicity. AdCMV.b-gal/AdCMV.Null infected cells demonstrated a significant rise in the concentration of LDH in the supernatant, whereas the concentration of LDH in AdCMV.b-gal/AdCMV.p21 infected cells was not different from that in mock treated cells (Figure 4b ). To verify that the observed protective effect of coexpression of p21 was not dependent on the type of promoter and/or transgene used, we changed the Ad vector combination by replacing AdCMV.b-gal with AdRSV.b-gal or AdRSV-hAAT.2. Independent of the type of promoter or transgene used, coinfection of AdCMV.p21 with AdRSV.b-gal or AdRSV-hAAT.2 resulted in protection against Ad vector induced cytotoxicity (data not shown). Moreover, independent of the type of promoter (Figure 5a and b) or the type of transgene used (Figure 5c ), coinfection with AdCMV.p21 resulted in increased transgene expression as compared to coinfection with AdCMV.Null.
Ad vector mediated gene transfer of p21 enhances the expression of a transgene delivered by a second Ad vector in vivo Coexpression of p21 supported transgene expression of a second Ad vector in LoVo cells. To see if this observation was reproducible in vivo, we used the model of adenovirus mediated gene transfer to the liver by systemic administration. 20 To this end, we injected 2.0 Â 10 9 pfu (plaque-forming units) of a 1:1 mixture of either AdCMV.Null/AdRSV-hAAT.2 or AdCMV.p21/ AdRSV-hAAT.2 intravenously into SCID mice and p21 prevents adenovirus-induced apoptosis G Wolff et al analyzed serum levels of hAAT over a period of 150 days. Consistent with previous data by others infecting with only AdRSV-hAAT.2, levels of hAAT in the serum of AdCMV.Null/AdRSV-hAAT.2 SCID mice declined rapidly over time. 21 In contrast, expression remained stable for 50 days in the group of AdCMV.p21/AdRSV-hAAT.2 infected animals. Moreover, at the end of the subsequent decline until day 150 the resultant serum concentration of hAAT was about 100-fold higher compared to the control animals ( Figure 6 ). 
Discussion
In this study, we identified that Ad vector associated cytotoxicity and induction of apoptosis is mediated by cell cycle dysregulation due to uncoupling of S-phase and mitosis which can be prevented by coexpression of p21. Therefore, we propose the strategy of coexpression of p21 to supplement Ad vector mediated gene transfer. Because p21 is an apoptosis preventing cell cycle regulator without oncogenic potency, 13 this strategy may be of special interest in safety strategies in human gene therapy.
Differing results have been generated regarding Ad vector associated cytotoxicity and induction of apoptosis. In vitro, some groups observed no or only marginal effects, whereas others demonstrated cell cycle dysregulation with or without the presence of apoptosis. 10, 18, 19 In vivo, Ad vector associated cytotoxicity was described as a result of cell cycle activation and ballooning degeneration of infected hepatocytes. 22, 23 Our data suggest that the different observations made in vitro and in vivo can be explained, at least in part, by the mechanism of S/M uncoupling associated with induction of apoptosis. As demonstrated Ad vector infection resulted in cell cycle dysregulation, an increase in the overall cell size and grossly deformed, multiple nuclei and the occurrence of apoptosis.
The mechanism of induction of apoptosis due to S/M uncoupling was identified in p21 defective cells. Upon cellular stress, these cells undergo additional rounds of S-phases without entering mitosis leading to polyploidy and subsequent apoptosis. 24, 25 However, cell systems used in our study were positive for p21. This indicates that after infection, the Ad vector by itself might interfere directly or indirectly with a p21 dependent checkpoint. Our suggestion of the level of active p21 as a possible target is underlined by the observation of stoichiometric binding to and inactivation of p21 by cyclin B/CDC2 complexes which are activated upon Ad vector infection. 10, 15 Conflicting data have been published concerning the effects AdCMV.p21 on tumor cell lines and their xenotransplants in immunocompromised mice. Whereas p21 prevents adenovirus-induced apoptosis G Wolff et al some groups observed induction of tumor cell death and apoptosis, 26 others demonstrated a cytoprotective effect. 27, 28 We observed absence of cytotoxicity in cultures of cells lines and human primary hepatocytes after infection with AdCMV.p21. Strikingly, this protective effect was seen even in the presence of adenovirus replication in 293 cells. Our observation that p21 can protect against cytotoxicity in the presence of adenoviral replication is consistent with other results demonstrating that p21 by controlled cell proliferation can protect from cell death. 24, 25, 29 As our experiments in human primary hepatocytes demonstrated, the cell protective effect of p21 can be applied especially to Ad vector mediated gene transfer to the liver. The liver is very sensitive to cellular stress and cytotoxicity because of the great array of pathways during the acute phase response of injury. 30 As a result of the acute phase response after Ad vector infection, there is rapid elimination of transgene expression and Ad vector even before activation of the adaptive immune system e.g. cytotoxic T cells. 20, 23, [31] [32] [33] [34] [35] [36] This conclusion is underlined by the use of SCID mice in our in vivo experiments resulting in an enhanced transgene expression of hAAT after coinfection of AdRSV-hAAT.2 and AdCMV.p21.
One major concern in human gene therapy is the extrapolation from the situation in animal experiments to that in humans. To come as close as possible to a clinical situation, we employed human primary hepatocytes. To answer the question if the protective effect of p21 was also demonstrable in human hepatocytes, we measured release of the liver enzymes AST, ALT and LDH. As seen in our results, there was an increase in AST, ALT and LDH after AdCMV.b-gal infection. This was reduced to almost the level of mock infected hepatocytes in AdCMV.p21/AdCMV.b-gal infected cultures despite the fact that the resulting MOI in the coinfection was twice that in only AdCMV. b-gal infected human primary hepatocytes.
Various strategies to eliminate Ad vector associated side effects have been investigated like further deletion of viral genes, 22,37 pretreatment of animals with antiinflammatory drugs, 21, 38 temporary depletion of the local innate immune system, 20 inactivation of the adaptive immune system [39] [40] [41] or coexpression of oncogenes like bcl-2. 12 In this context, the most promising approach under development is the 'gutless vector' where all adenoviral genes are deleted. However, considering all these strategies from a clinical point of view, the possibility of new disadvantages or side effects emerge like higher susceptibility for infectious diseases due to unspecific suppression of the immune system, decreased efficacy in transgene expression through the deletion of activating genes of the Ad vector, 8, 9, 31 contamination with helper adenovirus 37 or oncogenic transformation of the infected cell by unspecific blockage of apoptosis. 42 Therefore, strategies are desirable that limit or diminish Ad vector associated side effects without creating new risks for the patients. 43 In this respect, coexpression of p21 with an Ad vector carrying a therapeutic gene of choice may be one alternative as observed by lowering of the enzyme levels of LDH, AST and ALT in Ad vector infected cells. Taken together, our data suggest that coexpression of p21 and Ad vector carrying a therapeutic gene of choice may be a promising strategy to avoid cytotoxicity and induction of apoptosis and, therefore, leading to improved safety in human gene therapy.
Material and methods
Cell lines and human primary hepatocytes
All cell lines used were purchased from ATCC. The human colon carcinoma cell lines LoVo, LS174T, SW620, the human breast cancer cell line BT549 and the human embryonic kidney cell line 293 were maintained in DMEM or RPMI 1640 (LS174T, SW620), supplemented with 10% FBS and 2 mM glutamine at 371C, 5% CO 2 in a humidified atmosphere (all culture reagents Life Technologies, Karlsruhe, FRG). In accordance with institutional guidelines, human hepatocytes were isolated from normal liver wedge resections by collagenase-P (Roche Diagnostics, Grenzau, Germany) digestion as recently described. 44, 45 Briefly, after enzymatic digestion hepatocytes were separated from non-parenchymal cells by differential centrifugation at 50 g and then passed over a 30% Percoll (Pharmacia, Freiburg, FRG) gradient at a concentration of 10 6 cells/ml Percoll to obtain a highly purified cell population. Hepatocyte purity and viability assessed by microscopy was greater than 95% and viability consistently exceeded 90% by trypan blue exclusion. 45 The primary hepatocytes were cultured in Williams Medium E, supplemented with 10% heatinactivated (90 min at 701C) FBS, 1% penicillin/streptomycin, 15 mM hepes buffer (all Life Technologies, Karlsruhe, FRG), 2.0 mg/ml insulin and 0.35 nM Hydrocortisone (both Sigma, Deisenhofen, FRG) at 371C, 5% CO 2 in a humidified atmosphere.
Construction and propagation of recombinant adenovirus vector
All recombinant Ad vectors are based on adenovirus type 5 and are replication deficient due to deletion in the E1 region and are also partially deleted in E3. AdCMV.p21 carries the cDNA of p21 driven by the CMV promoter and was constructed as described. 18 The AdCMV.Rb
Dcdk codes for a non-phosphorylable Rb protein which is mutated at 10 phosphorylation sites and, therefore, not subject to phosphorylation. 17 The Rb Dcdk is driven by the CMV promoter and was constructed as described. 18 The Ad vector AdRSVhAAT.2 carries the cDNA of the hAAT driven by the Rous-Sarcoma-virus promoter (RSV). 21 The Ad vector AdRSV.b-gal expresses E.coli b-galactosidase under the control of the RSV promoter. 21 The Ad vector AdCMV.bgal expresses E.coli b-galactosidase under the control of the CMV promoter and the AdCMV.Null carries an empty expression cassette. 46 AdCMV.p53 contains the cDNA of p53 under the control of the CMV promoter. 47 All vectors were propagated on 293 cells, purified and stored at À801C as described previously. 48, 49 Particle titers were evaluated by optical density measurement and were between 1.8 Â 10 12 and 1.7 Â 10 13 particle/ml. The titer of pfu for each preparation was determined by plaque assay on 293 cells and ranged from 7 Â 10 9 to 3.8 Â 10
11 pfu/ml.
Analysis of human a 1-antitrypsin expression
Serum levels of hAAT were quantified by a sandwich-ELISA as described. 21 Briefly, MaxiSorp F16 ELISA plates 
Analysis of b-galactosidase expression
For b-galactosidase transgene expression, a sensitive chemoluminescence reporter gene assay (Galacto-Light Plus; Tropix, Bedford, MA, USA) was used. Cells were treated as described elsewhere. 50 Briefly, cells were rinsed twice with PBS (Life Technologies, Karlsruhe, FRG) and lysed with 100 mM potassium phosphate pH 7.8, 0.2% Triton X-100 and 1 mM dithiothreitol. Then cells were centrifuged for 5 min at 14.000 g and the resulting supernatants were used to determine the b-galactosidase activity as described by the manufacturer.
Glucose measurement and analysis of liver enzymes
Cells were infected with indicated multiplicity of infection following a procedure described elsewhere. 50 To measure the amount of glucose and the membrane leakage of LDH, AST and ALT, cell culture supernatants of all experiments were analyzed with an enzyme electrode (esat 6660-2, Prü fgerätewerk Mendingen, Freital, FRG) and in a laboratory system (Synchron CX5, Beckman Coulter, Palo Alto, CA, USA)
Assessment of apoptosis and cell cycle distribution by FACS analysis
For experiments using FACS analysis 8 Â 10 5 cells were seeded in triplicates in 10 cm dishes and cultured overnight to allow adherence. Next morning, cells were infected with Ad vectors at the indicated MOI as described. 50 Cells were harvested by trypsinization at the indicated time points. For detection of apoptosis, cells were stained with FITC-conjugated Annexin V and propidium iodide (PI) using the Annexin V kit (Immunotech, Marseille, France) as indicated by the manufacturer. Samples were subsequently analyzed by flow cytometry (FACScan, Becton Dickinson, San Jose, CA, USA) for the presence of viable (FITC-negative and PInegative) and apoptotic (FITC-positive) cells which included both, primary (PI-negative) and secondary (PI-positive), apoptotic subpopulations. For analysis of cell cycle distribution, FITC-Annexin V-stained samples were fixed and permeabilized. Briefly, following two washes with PBS, the cell pellet was fixed with icecold 70% ethanol for 1 h at 41C. After two additional washes, cells were resuspended in 0.2 ml PBS containing 1.0 mg/ ml PI, pH 7.5 and 0.5 mg/ml RNase (type I-A; Boehringer Mannheim, Mannheim, Germany) at room temperature in the dark for 30 min and subsequently analyzed by flow cytometry. Cell cycle analysis was performed using either CellQuest software (Becton Dickinson, San Jose, CA, USA) or ModFit LT (Verity, Topsham, ME, USA). Cell aggregates were excluded from the analysis by using the Doublet Discriminating Module (Becton Dickinson).
In situ detection of apoptosis
Apoptosis was detected in situ by direct immunoperoxidase detection of digoxigenin-labeled DNA double-strand breaks in single cells (TUNEL assay) as described by the manufacturer ('Apop Tag' Plus-In Situ Apoptosis Detection Kit, ONCOR, Inc., Gaithersburg, MD, USA) with the following exceptions. On microscope slides, air-dried cells (5 Â 10 5 cells) were incubated in 4% paraformaldehyde for 10 min at room temperature, followed by three washes with PBS for 10 min each prior to incubation in 0.1% Triton X-100 in PBS for 10 min at room temperature After an additional three washes with PBS we followed the manufacturer's protocol.
Animal studies
C.B17/BlnA-Scid/Scid mice (SCID mice) were obtained from our own breeding colony at the animal core facility of the Max Delbrueck Center and maintained under specific pathogen-free conditions (SPF). All newborn mice were tested for leakiness and only negative animals were kept. Mice of the same sex aged 8-10 weeks and weighing 20-22 g were used in each experiment. For each experiment, the indicated dose and type of the Ad vector was given intravenously either by tail vein or jugular vein injection as previously described. 46 To analyze serum levels of hAAT after adenovirus-mediated gene transfer, blood was collected and processed as described. 21 
